Metlife (MET-PF) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $17.22, +1.29% vs the prior close of $17.00.
- Volume 127.89K shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MET-PF rises 1.3% to $17.22. Closed at $17.22, +1.29% vs the prior close of $17.00. Day range $17.14–$17.42, opened at $17.15.
MET-PF daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — MET-PF rises 1.3% to $17.22
- Closed at $17.22, +1.29% vs the prior close of $17.00. Day range $17.14–$17.42, opened at $17.15.
- Volume was 127.89K shares, 0.9x its 50-day average of 139.45K.
- Price is -1.3% vs its 50-day average ($17.45) and -7.8% vs its 200-day average ($18.67).
- 52-week range $16.61–$21.13; today's close sits at 13% of that range, 18.5% below the 52-week high.
Oct 14, 2026 — MET-PF dips 0.8% to $17.00 on 2.7x normal volume
- Closed at $17.00, -0.76% vs the prior close of $17.13. Day range $16.82–$17.09, opened at $16.94.
- Volume was 359.92K shares, 2.7x its 50-day average of 133.78K — unusually heavy trading.
- Price is -2.7% vs its 50-day average ($17.47) and -9.0% vs its 200-day average ($18.68).
- 52-week range $16.61–$21.13; today's close sits at 9% of that range, 19.5% below the 52-week high.
Oct 13, 2026 — MET-PF rises 2.4% to $17.13
- Closed at $17.13, +2.39% vs the prior close of $16.73. Day range $16.68–$17.15, opened at $16.73.
- Volume was 139.09K shares, 1.0x its 50-day average of 133.07K.
- Price is -2.1% vs its 50-day average ($17.49) and -8.4% vs its 200-day average ($18.70).
- 52-week range $16.61–$21.13; today's close sits at 12% of that range, 18.9% below the 52-week high.
Oct 12, 2026 — MET-PF dips 1.1% to $16.73, a 52-week low
- Closed at $16.73, -1.06% vs the prior close of $16.91. Day range $16.65–$16.99, opened at $16.84.
- Volume was 122.72K shares, 0.9x its 50-day average of 133.10K.
- Price is -4.5% vs its 50-day average ($17.52) and -10.6% vs its 200-day average ($18.71).
- 52-week range $16.61–$21.13; today's close sits at 3% of that range, 20.8% below the 52-week high.
Oct 9, 2026 — MET-PF ends flat (-0.3%) to $16.91
- Closed at $16.91, -0.29% vs the prior close of $16.96. Day range $16.79–$16.95, opened at $16.95.
- Volume was 135.61K shares, 1.0x its 50-day average of 132.14K.
- Price is -3.6% vs its 50-day average ($17.54) and -9.7% vs its 200-day average ($18.72).
- 52-week range $16.61–$21.13; today's close sits at 7% of that range, 20.0% below the 52-week high.
Oct 8, 2026 — MET-PF rises 0.4% to $16.96
- Closed at $16.96, +0.36% vs the prior close of $16.90. Day range $16.75–$17.00, opened at $16.84.
- Volume was 130.07K shares, 1.0x its 50-day average of 131.69K.
- Price is -3.5% vs its 50-day average ($17.57) and -9.5% vs its 200-day average ($18.74).
- 52-week range $16.61–$21.13; today's close sits at 8% of that range, 19.7% below the 52-week high.
Oct 7, 2026 — MET-PF ends flat (-0.2%) to $16.90
- Closed at $16.90, -0.18% vs the prior close of $16.93. Day range $16.68–$16.90, opened at $16.69.
- Volume was 98.36K shares, 0.7x its 50-day average of 131.25K.
- Price is -4.0% vs its 50-day average ($17.60) and -9.9% vs its 200-day average ($18.75).
- 52-week range $16.61–$21.13; today's close sits at 6% of that range, 20.0% below the 52-week high.
Oct 6, 2026 — MET-PF rises 0.4% to $16.93
- Closed at $16.93, +0.42% vs the prior close of $16.86. Day range $16.74–$16.99, opened at $16.80.
- Volume was 117.58K shares, 0.9x its 50-day average of 129.85K.
- Price is -3.9% vs its 50-day average ($17.62) and -9.8% vs its 200-day average ($18.76).
- 52-week range $16.61–$21.13; today's close sits at 7% of that range, 19.9% below the 52-week high.
Oct 5, 2026 — MET-PF dips 1.4% to $16.86
- Closed at $16.86, -1.40% vs the prior close of $17.10. Day range $16.68–$17.00, opened at $16.97.
- Volume was 163.49K shares, 1.3x its 50-day average of 127.61K.
- Price is -4.5% vs its 50-day average ($17.65) and -10.2% vs its 200-day average ($18.78).
- 52-week range $16.61–$21.15; today's close sits at 6% of that range, 20.3% below the 52-week high.
Oct 2, 2026 — MET-PF ends flat (-0.2%) to $17.10
- Closed at $17.10, -0.23% vs the prior close of $17.14. Day range $16.92–$17.47, opened at $17.16.
- Volume was 158.91K shares, 1.3x its 50-day average of 125.79K.
- Price is -3.3% vs its 50-day average ($17.68) and -9.0% vs its 200-day average ($18.79).
- 52-week range $16.61–$21.16; today's close sits at 11% of that range, 19.2% below the 52-week high.
MET-PF latest news & SEC filings
Every SEC filing by or about MET-PF in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Johnson Jeh C. received an award of 544 shares at $94.35 (≈$51.33K) on Oct 1, 2026; now holds 10,101
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hubbard Robert Glenn received an award of 941 shares at $94.35 (≈$88.78K) on Oct 1, 2026; now holds 109,132
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mumenthaler Christian Stephane received an award of 544 shares at $94.35 (≈$51.33K) on Oct 1, 2026; now holds 4,018
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Harris Carla A received an award of 544 shares at $94.35 (≈$51.33K) on Oct 1, 2026; now holds 11,701
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Weinberger Mark A received an award of 544 shares on Oct 1, 2026; now holds 19,932
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 28, 2026 · Form N-PX — Annual proxy voting record
Annual proxy voting record
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form 13F-HR — Quarterly holdings report filed by an institutional investment manager
Quarterly holdings report filed by an institutional investment manager
Aug 6, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $724.00M (prior year $604.00M) (+19.9% vs Jun 30, 2025)
- Net income: $736.00M (prior year $729.00M) (+1.0% vs Jun 30, 2025)
- Diluted EPS: $1.09 (prior year $1.03) (+5.8% vs Jun 30, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jun 22, 2026 · Form S-8 POS — S-8 POS filing
S-8 POS filing
Things to know before you trade MET-PF
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 4, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.68% (largest 2.4%). That is a relatively calm stock.
- Liquidity: about 159.09K shares (≈$2.74M) trade per day on average.
- 52-week position: $17.22 vs a range of $16.61–$21.13 (13% of the range).
- Dividends: last ex-dividend date Aug 31, 2026 ($0.2969/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 1 sales; latest: Marlene Debel sold 21,312 shares on Jun 1, 2026.
- Latest filings: 8-K Sep 24, 2026; 8-K Aug 17, 2026; 10-Q Aug 6, 2026.
- Share count: 635.48M shares outstanding (Jul 31, 2026), -4.4% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Life Insurance.
MET-PF market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 17.15 | 17.42 | 17.14 | 17.22 | 127.89K |
| Oct 14, 2026 | 16.94 | 17.09 | 16.82 | 17.00 | 359.92K |
| Oct 13, 2026 | 16.73 | 17.15 | 16.68 | 17.13 | 139.09K |
| Oct 12, 2026 | 16.84 | 16.99 | 16.65 | 16.73 | 122.72K |
| Oct 9, 2026 | 16.95 | 16.95 | 16.79 | 16.91 | 135.61K |
| Oct 8, 2026 | 16.84 | 17.00 | 16.75 | 16.96 | 130.07K |
| Oct 7, 2026 | 16.69 | 16.90 | 16.68 | 16.90 | 98.36K |
| Oct 6, 2026 | 16.80 | 16.99 | 16.74 | 16.93 | 117.58K |
| Oct 5, 2026 | 16.97 | 17.00 | 16.68 | 16.86 | 163.49K |
| Oct 2, 2026 | 17.16 | 17.47 | 16.92 | 17.10 | 158.91K |
| Oct 1, 2026 | 16.77 | 17.15 | 16.65 | 17.14 | 133.79K |
| Sep 30, 2026 | 16.79 | 16.80 | 16.64 | 16.80 | 279.79K |
| Sep 29, 2026 | 16.87 | 16.91 | 16.61 | 16.83 | 141.49K |
| Sep 28, 2026 | 16.94 | 16.97 | 16.80 | 16.91 | 76.97K |
| Sep 25, 2026 | 17.06 | 17.11 | 16.91 | 17.01 | 280.17K |
| Sep 24, 2026 | 17.05 | 17.10 | 16.90 | 17.03 | 171.27K |
| Sep 23, 2026 | 17.17 | 17.22 | 16.97 | 17.12 | 229.53K |
| Sep 22, 2026 | 17.23 | 17.31 | 17.11 | 17.20 | 94.56K |
| Sep 21, 2026 | 17.31 | 17.37 | 17.17 | 17.22 | 114.69K |
| Sep 18, 2026 | 17.27 | 17.30 | 17.16 | 17.29 | 105.82K |
About Metlife
Metlife (MET-PF) is listed on the NYSE and classified by the SEC under “Life Insurance”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1099219.
MET-PF board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Carlos M Gutierrez | Director | Apr 3, 2026 |
| Daniel S Glaser | Director | Sep 10, 2026 |
| Robert Glenn Hubbard | Director | Sep 10, 2026 |
| Carla A Harris | Director | Sep 10, 2026 |
| Laura J Hay | Director | Sep 10, 2026 |
| Jeh C. Johnson | Director | Sep 10, 2026 |
| William E Kennard | Director | Sep 10, 2026 |
| Michel Khalaf | President & CEO | Mar 4, 2026 |
| Diana Mckenzie | Director | Sep 10, 2026 |
| Denise M Morrison | Director | Apr 3, 2026 |
| Christian Stephane Mumenthaler | Director | Sep 10, 2026 |
| Michelle Seitz | Director | Jun 18, 2026 |
| Mark A Weinberger | Director | Jun 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Monica M Curtis | EVP & Chief Legal Officer | Mar 4, 2026 |
| Marlene Debel | EVP & Chief Risk Officer | Sep 2, 2026 |
| Michel Khalaf | President & CEO | Mar 4, 2026 |
| John D. Mccallion | EVP & Chief Financial Officer | Sep 2, 2026 |
| Adrienne Karen O'Neill | EVP & Chief Accounting Officer | May 4, 2026 |
| Bill Pappas | EVP, Global Tech. & Ops. | Sep 2, 2026 |
| Shurawl Sibblies | EVP & Chief HR Officer | Mar 4, 2026 |
| Ramy Tadros | President, U.S. Business | Sep 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 1, 2026 | Marlene Debel | Sale | 21,312 | $81.59 |
MET-PF financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $2.44B | $3.38B | 4.71 | $17.09B |
| Dec 31, 2024 | $2.25B | $4.43B | 5.94 | $14.60B |
| Dec 31, 2023 | $2.23B | $1.58B | 1.81 | $13.72B |
| Dec 31, 2022 | $2.11B | $5.28B | 6.30 | $13.04B |
| Dec 31, 2021 | $2.07B | $6.86B | 7.65 | $12.35B |
Latest balance sheet: total assets $759.37B, total liabilities $731.41B, cash $19.30B (as of Jun 30, 2026).
MET-PF earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $18.11 |
| May 6, 2026 | 8-K Item 2.02 (results) | $19.15 |
| Feb 4, 2026 | 8-K Item 2.02 (results) | $19.69 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $20.43 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $20.20 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $19.58 |
| Feb 5, 2025 | 8-K Item 2.02 (results) | $21.15 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $22.11 |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| May 1, 2024 | 8-K Item 2.02 (results) | — |
| Jan 31, 2024 | 8-K Item 2.02 (results) | — |
| Nov 1, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Life Insurance
Jackson Financial (JXN)Metlife (MET)Corebridge Financial (CRBG)Prudential Financial (PRU)Reinsurance Group Of America (RGA)Aegon (AEG)Voya Financial (VOYA)Globe Life (GL)Lincoln National (LNC)Manulife Financial (MFC)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on MET-PF
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.